Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

873 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Osa A, Uenami T, Koyama S, Fujimoto K, Okuzaki D, Takimoto T, Hirata H, Yano Y, Yokota S, Kinehara Y, Naito Y, Otsuka T, Kanazu M, Kuroyama M, Hamaguchi M, Koba T, Futami Y, Ishijima M, Suga Y, Akazawa Y, Machiyama H, Iwahori K, Takamatsu H, Nagatomo I, Takeda Y, Kida H, Akbay EA, Hammerman PS, Wong KK, Dranoff G, Mori M, Kijima T, Kumanogoh A. Osa A, et al. Among authors: hamaguchi m. JCI Insight. 2018 Oct 4;3(19):e59125. doi: 10.1172/jci.insight.59125. JCI Insight. 2018. PMID: 30282824 Free PMC article.
Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports.
Koba T, Kijima T, Takimoto T, Hirata H, Naito Y, Hamaguchi M, Otsuka T, Kuroyama M, Nagatomo I, Takeda Y, Kida H, Kumanogoh A. Koba T, et al. Among authors: hamaguchi m. Medicine (Baltimore). 2017 Feb;96(6):e6087. doi: 10.1097/MD.0000000000006087. Medicine (Baltimore). 2017. PMID: 28178168 Free PMC article.
Combination chemotherapy with intermittent erlotinib and pemetrexed for pretreated patients with advanced non-small cell lung cancer: a phase I dose-finding study.
Minami S, Kijima T, Takahashi R, Kida H, Nakatani T, Hamaguchi M, Takeuchi Y, Nagatomo I, Yamamoto S, Tachibana I, Komuta K, Kawase I. Minami S, et al. Among authors: hamaguchi m. BMC Cancer. 2012 Jul 18;12:296. doi: 10.1186/1471-2407-12-296. BMC Cancer. 2012. PMID: 22809298 Free PMC article. Clinical Trial.
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status.
Minami S, Kijima T, Hamaguchi M, Nakatani T, Koba T, Takahashi R, Takeuchi Y, Kida H, Nagatomo I, Yamamoto S, Tachibana I, Komuta K, Kawase I. Minami S, et al. Among authors: hamaguchi m. Lung Cancer. 2013 Nov;82(2):271-5. doi: 10.1016/j.lungcan.2013.07.022. Epub 2013 Aug 6. Lung Cancer. 2013. PMID: 23993733 Clinical Trial.
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study.
Otsuka T, Nishida S, Shibahara T, Temizoz B, Hamaguchi M, Shiroyama T, Kimura K, Miyake K, Hirata H, Mizuno Y, Yagita M, Manabe Y, Kuroda E, Takeda Y, Kida H, Ishii KJ, Kumanogoh A. Otsuka T, et al. Among authors: hamaguchi m. BMC Cancer. 2022 Jul 7;22(1):744. doi: 10.1186/s12885-022-09818-4. BMC Cancer. 2022. PMID: 35799134 Free PMC article. Clinical Trial.
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysis.
Naito Y, Tamiya A, Tamiya M, Kimura Y, Hamaguchi M, Saijo N, Kanazu M, Tokura S, Shiroyama T, Morisita N, Omachi N, Suzuki H, Okamoto N, Okishio K, Hirashima T, Atagi S. Naito Y, et al. Among authors: hamaguchi m. Medicine (Baltimore). 2017 Sep;96(35):e7884. doi: 10.1097/MD.0000000000007884. Medicine (Baltimore). 2017. PMID: 28858103 Free PMC article.
A lung abscess caused by secondary syphilis - the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report.
Futami S, Takimoto T, Nakagami F, Satoh S, Hamaguchi M, Kuroyama M, Miyake K, Koyama S, Iwahori K, Hirata H, Nagatomo I, Takeda Y, Kida H, Kumanogoh A. Futami S, et al. Among authors: hamaguchi m. BMC Infect Dis. 2019 Jul 9;19(1):598. doi: 10.1186/s12879-019-4236-4. BMC Infect Dis. 2019. PMID: 31288744 Free PMC article.
A Rare Case of Pleomorphic Carcinoma of the Lung Harboring an Anaplastic Lymphoma Kinase (ALK) Rearrangement.
Shiroyama T, Tanaka A, Tamiya M, Hamaguchi M, Osa A, Takeoka S, Tani E, Azuma Y, Morishita N, Suzuki H, Okamoto N, Kimura K, Kadota Y, Kawahara K, Hirashima T, Kawase I. Shiroyama T, et al. Among authors: hamaguchi m. Intern Med. 2015;54(21):2741-3. doi: 10.2169/internalmedicine.54.4474. Epub 2015 Nov 1. Intern Med. 2015. PMID: 26521903 Free article.
Emergency department visits after hours by lung cancer patients in Japan.
Minami S, Yamamoto S, Ogata Y, Takeuchi Y, Hamaguchi M, Koba T, Futami S, Nishijima Y, Komuta K. Minami S, et al. Among authors: hamaguchi m. Support Care Cancer. 2013 Sep;21(9):2443-51. doi: 10.1007/s00520-013-1814-7. Epub 2013 Apr 18. Support Care Cancer. 2013. PMID: 23595560
873 results